← Back to Dashboard

RUBICON Rubicon Research Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 1,486.70
+0.00%
1-year price · range ₹1,477–₹1,861

RUBICON Chart daily candles · add any indicator · computed in your browser

Loading chart…

Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.

Live setups screens RUBICON is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about RUBICON

Rubicon Research Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Rubicon Research Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Rubicon Research Ltd. is balanced between accumulation and distribution forces.

F&O Positioning EOD derivatives setup

Buildup Class
—
no futures data
Futures OI
—
EOD details
Option PCR (OI)
—
no EOD options
Max Pain Strike
—
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,486.70
yesterday's EOD close
Index Contribution
—
not a Nifty 50 constituent
Traded Volume
—
live shares traded today
Upcoming Earnings
—
no report scheduled

Technical Snapshot as of 2026-10-19 close · from 36 sessions of price history

RSI (14)
28.4
oversold
52-Week High
₹ 1,880.50
-20.9% from high
52-Week Low
₹ 1,450.50
+2.5% above low
200-DMA
—
—
50-DMA
—
—
1-Year Return
—
1M -15.1%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
85.6
price / earnings
P/B
19.0
price / book
ROE
—
return on equity
Market Cap
₹ 24,611 Cr
total market value
Dividend Yield
0.10%
trailing yield
EPS (TTM)
₹ 17.36
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-08-26 BUY ₹ 1,660.00 140.00 ARANDA INVESTMENTS PTE. LTD.
2026-08-26 SELL ₹ 1,660.00 140.00 GENERAL ATLANTIC SINGAPORE RR PTE LTD

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

No recent news articles found for this stock.

RUBICON — frequently asked questions

What is the Rubicon Research Ltd. share price today?

RUBICON is trading at ₹1,486.70 (+0.00% vs previous close), per the latest update on this page.

What is the P/E ratio of Rubicon Research Ltd.?

RUBICON (Rubicon Research Ltd.) has a trailing twelve-month P/E ratio of 85.6.

What is the market cap of Rubicon Research Ltd.?

RUBICON has a market capitalisation of approximately ₹24,611 crore.

Is RUBICON near its 52-week high?

RUBICON is trading -20.9% from its 52-week high of ₹1,880.50 as of 2026-10-19.

What is the RSI of RUBICON?

The 14-day RSI of RUBICON is 28.4, which is considered oversold.

Are FIIs or big investors buying RUBICON?

Strota tracks every bulk and block deal in RUBICON with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.